14
Dec
2026

Aptar Pharma

Exhibitor at CPHI Middle East 2026 stand H1.W102
About Us

Aptar Pharma – your go-to drug delivery expert, from formulation to patient – for proven drug delivery solutions and services, supports pharmaceutical companies worldwide to develop safe, efficient and compliant medicines. Our innovative drug delivery systems, components and active material solutions serve the widest range of delivery routes. Our digital healthcare solutions help improve patient adherence and treatment experience, while our Aptar Pharma Services help accelerate and derisk the drug development journey. Aptar Pharma is part of AptarGroup, Inc. (NYSE: ATR)www.aptar.com/pharma

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    France
  • On CPHI since:
    2015
  • Employees:
    5000+
Company types
Packaging supplier/manufacturer
Primary activities
Contract Research Organisation
Medical Devices
Packaging & drug delivery
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Middle East 2026
  • 14 Dec 2026 - 16 Dec 2026
  • Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
  • Visit us at stand H1.W102

Products Featured at CPHI Middle East 2026

  • APF Futurity™

    Product APF Futurity™

    APF  Futurity™ is our first completely recyclable metal-free nasal spray pump, developed to deliver preservative-free multi-dose nasal saline and comparable OTC formulations.

    APF  Futurity™ has been certified for complete recyclability by cyclosHTP (GER, NL, IRE) and ac...
  • Orbital™ DPI (Dry Powder Inhaler)

    Product Orbital™ DPI (Dry Powder Inhaler)

    Orbital™ DPI is Aptar Pharma’s next-generation dry powder inhaler platform engineered for high-dose pulmonary drug delivery. Designed with patient-centric principles, Orbital™ enables progressive dispensing from a sealed puck, allowing multiple gentle inhalations to deliver large powder payloads withou...

Aptar Pharma Resources (1)

  • Designing for Patients: Ergonomic Insights Driving Next-Generation Nasal Delivery Solutions

    Industry Webinar Designing for Patients: Ergonomic Insights Driving Next-Generation Nasal Delivery Solutions

    The Nasal drug delivery market is experiencing high growth and scientific developments, providing a non-invasive route for systemic and CNS therapies. Innovations in device design, formulation science, and targeting strategies are improving bioavailability, patient usability, and therapeutic precision. Direct to CNS delivery and the development pathway bring together patients, formulation, and device to treat unmet market needs. This session explores the latest scientific breakthroughs, device-formulation integration, and translational strategies that are shaping the future of nasal drug delivery and expanding its potential across therapeutic areas.
    2026-01-29